{"url_path":"/sec/cadl/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1841387/0001193125-26-222904-index.html","accession_number":"0001193125-26-222904","cik":"0001841387","ticker":"CADL","issuer_name":"Candel Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1841387/0001193125-26-222904-index.html","primary_entity_key":"0001841387","primary_entity_name":"Candel Therapeutics, Inc."},"word_count":32,"has_tables":true,"body_markdown":"Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.\n\n(a) Recent Sales of Unregistered Equity Securities\n\nNone.\n\n(b) Use of Proceeds\n\nNot applicable.\n\n(c) Issuer Purchases of Equity Securities\n\nNone."}